These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 773533)

  • 1. Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives.
    Di Marco A; Casazza AM; Gambetta R; Supino R; Zunino F
    Cancer Res; 1976 Jun; 36(6):1962-6. PubMed ID: 773533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin.
    Supino R; Necco A; Dasdia T; Casazza AM; Di Marco A
    Cancer Res; 1977 Dec; 37(12):4523-8. PubMed ID: 922737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
    Studzian K; Wasowska M; Piestrzeniewicz MK; Wilmańska D; Szmigiero L; Oszczapowicz I; Gniazdowski M
    Neoplasma; 2001; 48(5):412-8. PubMed ID: 11845988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of daunomycin and adriamycin on various DNA polymerases.
    Zunino F; Gambetta R; Di Marco A; Zaccara A; Luoni G
    Cancer Res; 1975 Mar; 35(3):754-60. PubMed ID: 163690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
    Marco A; Arcamone F
    Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships among daunorubicin and adriamycin analogs.
    Henry DW
    Cancer Treat Rep; 1979 May; 63(5):845-54. PubMed ID: 455326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.
    Di Marco A; Casazza AM; Dasdia T; Necco A; Pratesi G; Rivolta P; Velcich A; Zaccara A; Zunino F
    Chem Biol Interact; 1977 Dec; 19(3):291-302. PubMed ID: 597963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypothesis concerning possible new derivatives of daunorubicin and adriamycin with enhanced DNA-binding properties.
    Neidle S
    Cancer Treat Rep; 1977 Aug; 61(5):928-9. PubMed ID: 890699
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis.
    Mizuno NS; Zakis B; Decker RW
    Cancer Res; 1975 Jun; 35(6):1542-6. PubMed ID: 1169109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cells.
    Kanter PM; Schwartz HS
    Cancer Res; 1979 Feb; 39(2 Pt 1):448-51. PubMed ID: 761217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and biological activities of disaccharide daunorubicins.
    Zhang G; Fang L; Zhu L; Aimiuwu JE; Shen J; Cheng H; Muller MT; Lee GE; Sun D; Wang PG
    J Med Chem; 2005 Aug; 48(16):5269-78. PubMed ID: 16078845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic studies on N-benzyladriamycin-14-valerate (AD 198), a highly lipophilic alkyl adriamycin analog.
    Lameh J; Chuang LF; Israel M; Chuang RY
    Anticancer Res; 1988; 8(4):689-93. PubMed ID: 3052250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition in vitro of DNA polymerase and RNA polymerases by daunomycin and adriamycin.
    Zunina F; Gambetta R; Di Marco A
    Biochem Pharmacol; 1975 Jan; 24(2):309-11. PubMed ID: 1089410
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Kanter PM; Schwartz HS
    Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of daunorubicin.
    Di Marco A; Cassinelli G; Arcamone F
    Cancer Treat Rep; 1981; 65 Suppl 4():3-8. PubMed ID: 7049379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC; Dong X; Gaudel G; Mitaku S; Monneret C; Gesson JP; Jacquesy JC; Mondon M; Renoux B; Andrianomenjanahary S; Michel S; Koch M; Tillequin F; Gerken M; Czech J; Straub R; Bosslet K
    J Med Chem; 1998 Sep; 41(19):3572-81. PubMed ID: 9733483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of the beta-anomer of doxorubicin with B and Z DNA.
    Britt M; Zunino F; Chaires JB
    Mol Pharmacol; 1986 Jan; 29(1):74-80. PubMed ID: 3945229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.